Charleston, WV7 Active Studies

Pulmonary Embolism Clinical Trials in Charleston, WV

Find 7 actively recruiting pulmonary embolism clinical trials in Charleston, WV. Connect with local research sites and explore new treatment options.

7
Active Trials
6
Sponsors
1,565
Enrolling

Recruiting Pulmonary Embolism Studies in Charleston

About Pulmonary Embolism Clinical Trials in Charleston

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 7 pulmonary embolism clinical trials recruiting participants in Charleston, WV. These studies are seeking a combined 1,565 participants. Research is being sponsored by University of Kansas Medical Center, Medical University of South Carolina, GlaxoSmithKline and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Charleston — FAQ

Are there pulmonary embolism clinical trials in Charleston?

Yes, there are 7 pulmonary embolism clinical trials currently recruiting in Charleston, WV. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Charleston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Charleston research site will contact you about next steps.

Are clinical trials in Charleston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Charleston studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 7 active trials in Charleston are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 13, 2026 from ClinicalTrials.gov